Antioxidant vitamins and cardiovascular disease

Nutrition Reviews

Volumn 55, Issue 1 II, 1997, Pages S53-S58

  Buring, Julie E ^a   Hennekens, Charles H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0030949707     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1997.tb06103.x     Document Type: Conference Paper

References (42)

1. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipo-protein that increase its atherogenicity. N Engl J Med 1989;320:915
2. Gaziano JM, Manson JE, Buring JE, Hennekens CH. Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 1992;669:249
3. Keaney JF Jr, Gaziano JM, Xu A, et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 1993;90:11880
4. Smith TL, Kummerow FA. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted anovulatory chickens. Atherosclerosis 1989;75:105
5. Wojcicki J, Rozewicka L, Barcew-Wiszniewska B, et al. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991;87:9
6. Verlangieri AJ, Bush M. Prevention and regression of atherosclerosis by alpha-tocopherol. J Am Coll Nutr 1992;11:131
7. Willis GC. An experimental study of the intimai ground substance in atherosclerosis. Can Med Assoc J 1953;69:17
8. Willis GC. The reversibility of atherosclerosis. Can Med Assoc J 1957;77:106
9. Shaish A, Daugherty A, O'Sullivan F, et al. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 1995;96:2075
10. Carew T, Schwenke D, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hypercholesterolemic rabbits. Proc Natl Acad Sci USA 1987;84:7725
11. Acheson RM, Williams DRR. Does consumption of fruit and vegetables protect against stroke? Lancet 1983;1:1191
12. Armstrong BK, Mann JL, Adelstein AM, Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chronic Dis 1975;36:673
13. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987;45:1368
14. Gey KF, Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989;570:268
15. Salonen JT, Solonen R, Seppanen K, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischemic heart disease in eastern Finnish men. Atherosclerosis 1988;70:155
16. Riemersma RA, Oliver M, Elton RA, et al. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur J Clin Nutr 1990;44:143
17. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444
18. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450
19. Gaziano JM, Branch LG, Manson JE, et al. A prospective study of beta-carotene in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995;5:255
20. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194
21. Kushi LH, Folsom AR, Prineas RJ, et al. Antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156
22. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery disease. Am J Cardiol 1985;56:226
23. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9 year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462
24. Street DA, Comstock GW, Salkeld RM, et al. A population based case-control study of serum antioxidants and myocardial infarction. Am J Epidemiol 1991;134:719
25. Hennekens CH, Buring JE. Epidemiology in medicine. Boston, MA: Little Brown, 1987
26. Steinberg D, workshop participants. Antioxidants in the prevention of human atherosclerosis: summary proceedings of a National Heart, Lung, and Blood Institute workshop, September 5-6, 1991, Bethesda, MD. Circulation 1992;85:2337
27. Blot WJ, Li J-Y, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483
28. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029
29. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins-benefits not yet proved. N Engl J Med 1994;330:1080
30. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150
31. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129
32. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145
33. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH. Beta carotene therapy for chronic stable angina [Abstract]. Circulation 1996;94(1, Suppl): 508
34. Haeger K. Long-time treatment of intermittent claudication with vitamin E. Am J Clin Nutr 1974;427:1179
35. Livingston PD, Jones C. Treatment of intermittent claudication with vitamin E. Lancet 1958;2:602
36. Williams HTG, Fenna D, MacBeth RA. Alpha-tocopherol in the treatment of intermittent claudication. Surg Gynecol Obstet 1971;132:662
37. Gillilan RE, Mandell B, Warbassee JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 1988;93:444
38. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781
39. Buring JE, Hennekens CH, for the Women's Health Study Research Group. The Women's Health Study: summary of the study design. J Myocardial Ischemia 1992;4:27
40. Manson JE, Gaziano JM, Spelsberg A, et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: rationale, design and methods. Ann Epidemiol 1995;5:261
41. HOPE Study Investigators. The HOPE (Heart Outcomes Prevention Evaluation) Study. The design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996;12:127
42. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860